Cargando…
Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
Feraheme, is a recently FDA-cleared superparamagnetic iron oxide nanoparticle (SPION)-based MRI contrast agent that is also employed in the treatment of iron deficiency anemia. Feraheme nanoparticles have a hydrodynamic diameter of 30 nm and consist of iron oxide crystallites complexed with a low mo...
Autores principales: | Bullivant, John P., Zhao, Shan, Willenberg, Brad J., Kozissnik, Bettina, Batich, Christopher D., Dobson, Jon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794737/ https://www.ncbi.nlm.nih.gov/pubmed/24065092 http://dx.doi.org/10.3390/ijms140917501 |
Ejemplares similares
-
A Case of Ferumoxytol (Feraheme(®)) Prompting Critical Modification to Our Patient Prebreast Magnetic Resonance Imaging Questionnaire
por: Samreen, Naziya, et al.
Publicado: (2019) -
Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018) -
Local hyperthermia for esophageal cancer in a rabbit tumor model: Magnetic stent hyperthermia versus magnetic fluid hyperthermia
por: LIU, JIAYI, et al.
Publicado: (2013) -
Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
por: Nguyen, Kim-Lien, et al.
Publicado: (2017) -
Imaging Tumor Necrosis with Ferumoxytol
por: Aghighi, Maryam, et al.
Publicado: (2015)